- Home
- LSTA vs CLPS Comparison
LSTA vs CLPS Comparison
Compare LSTA & CLPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTA
- CLPS
- Stock Information
- Founded
- LSTA 1980
- CLPS 2005
- Country
- LSTA United States
- CLPS Hong Kong
- Employees
- LSTA N/A
- CLPS N/A
- Industry
- LSTA Misc Health and Biotechnology Services
- CLPS Computer Software: Prepackaged Software
- Sector
- LSTA Health Care
- CLPS Technology
- Exchange
- LSTA Nasdaq
- CLPS Nasdaq
- Market Cap
- LSTA 24.1M
- CLPS 26.0M
- IPO Year
- LSTA N/A
- CLPS 2018
- Fundamental
- Price
- LSTA $2.48
- CLPS $0.91
- Analyst Decision
- LSTA Strong Buy
- CLPS
- Analyst Count
- LSTA 1
- CLPS 0
- Target Price
- LSTA $15.00
- CLPS N/A
- AVG Volume (30 Days)
- LSTA 15.7K
- CLPS 11.9K
- Earning Date
- LSTA 08-11-2025
- CLPS 03-05-2025
- Dividend Yield
- LSTA N/A
- CLPS 14.23%
- EPS Growth
- LSTA N/A
- CLPS N/A
- EPS
- LSTA N/A
- CLPS N/A
- Revenue
- LSTA $1,000,000.00
- CLPS $153,816,045.00
- Revenue This Year
- LSTA N/A
- CLPS N/A
- Revenue Next Year
- LSTA N/A
- CLPS N/A
- P/E Ratio
- LSTA N/A
- CLPS N/A
- Revenue Growth
- LSTA N/A
- CLPS 5.81
- 52 Week Low
- LSTA $1.87
- CLPS $0.68
- 52 Week High
- LSTA $4.20
- CLPS $1.70
- Technical
- Relative Strength Index (RSI)
- LSTA 45.67
- CLPS 42.08
- Support Level
- LSTA $2.36
- CLPS $0.90
- Resistance Level
- LSTA $2.86
- CLPS $0.93
- Average True Range (ATR)
- LSTA 0.23
- CLPS 0.05
- MACD
- LSTA -0.00
- CLPS -0.00
- Stochastic Oscillator
- LSTA 18.06
- CLPS 24.91
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.
About CLPS CLPS Incorporation
CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in the banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting services, Customized IT solution services, and others. Generating the majority of its revenue from the IT consulting service.